STUDY OF THE POLYMORPHISMS RS2234693 OF THE ESR1 GENE AND RS731236 OF THE VDR GENE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE-Reference-Cited by-同舟云学术

STUDY OF THE POLYMORPHISMS RS2234693 OF THE ESR1 GENE AND RS731236 OF THE VDR GENE IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE

Published:2022-11-12 Issue: Volume:33 Page:95-101
ISSN:1999-9127
Container-title:Молекулярная и прикладная генетика
language:
Short-container-title:Молекулярная и прикладная генетика

Author:

Khotko E. A.¹,Taganovich A. D.¹,Kadushkin A. G.¹

Affiliation:

1. Educational Institution "Belarusian State Medical University"

Abstract

The frequency of the occurrence of polymorphic variants rs2234693 (PvuII, T→C) of the ESR1 gene and rs731236 (TaqI, T→C) of the VDR gene was investigated in 95 patients with chronic obstructive pulmonary disease (COPD) and in 95 healthy people. A statistically significant increase (p = 0.006) in the frequency of the occurrence of the heterozygous TC genotype rs2234693 in the intron 1 of the ESR1 gene was found in the group of patients with COPD compared to the group of conditionally healthy people. The heterozygous TC genotype rs2234693 is associated with chronic obstructive pulmonary disease (OR = 5.21 CI = 1.43–19.0) was established. As for the rs731236 polymorphism of the VDR gene, there were no significant differences in the frequency of occurrence of one of the genotypes in patients with COPD and healthy people.

Publisher

National Academy of Sciences of Belarus

Reference29 articles.

1. Chung, K. F. Multifaceted mechanisms in COPD: inflammation, immunity, and tissue repair and destruction / K. F. Chung, I. M. Adcock // European Respiratory Journal. – 2008. – Vol. 31, № 6. – P. 1 334–1 356.

2. Barnes, P. J. Mechanisms in COPD: differences from asthma / P. J. Barnes // Chest. – 2000. – Vol. 117, № 2. – P. 10–14.

3. Gilmore, T. D. Introduction to NF-kappaB: players, pathways, perspectives / T. D. Gilmore // Oncogene. – 2006. – Vol. 25, № 51. – P. 6 680–6 684.

4. Saklatvala, J. The p38 MAP kinase pathway as a therapeutic target in inflammatory disease / J. Saklatvala // Curr. Opin. Pharmacol. – 2004. – Vol. 4, № 4. – P. 372–377.

5. The role of vitamin D in pulmonary disease: COPD, asthma, infection, and cancer / C. Herr [et al.] // Respir. Res. – 2011. – Vol. 12, № 1. – P. 2–9.